AU Patent

AU2016286548B2 — Solid forms and formulations of (S)-4-(8-amino-3-(1 -(but-2-ynoyl)pyrrolidin-2-yl)imidazo(1,5-a)pyrazin-1-yl)-N-(pyridin-2-yl)benzamide

Assigned to Acerta Pharma BV · Expires 2020-12-10 · 5y expired

What this patent protects

In some embodiments, the invention relates to crystalline solid forms, including polymorphs, hydrates, and salt forms, of(

USPTO Abstract

In some embodiments, the invention relates to crystalline solid forms, including polymorphs, hydrates, and salt forms, of(

Drugs covered by this patent

Patent Metadata

Patent number
AU2016286548B2
Jurisdiction
AU
Classification
—
Expires
2020-12-10
Drug substance claim
No
Drug product claim
No
Assignee
Acerta Pharma BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.